Loading...
Surgical Science Sweden AB (publ)
SUSRF•PNK
HealthcareMedical - Healthcare Information Services
$15.43
$0.45(2.99%)
Surgical Science Sweden AB (publ) (SUSRF) Financial Performance & Statements
Review Surgical Science Sweden AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.14%
↑ 0.14%
Operating Income Growth
-23.70%
↓ 23.70%
Net Income Growth
-43.73%
↓ 43.73%
Operating Cash Flow Growth
-42.41%
↓ 42.41%
Operating Margin
15.88%
↑ 15.88%
Gross Margin
64.43%
↑ 64.43%
Net Profit Margin
14.89%
↑ 14.89%
ROE
2.85%
↑ 2.85%
ROIC
2.70%
↑ 2.70%
Surgical Science Sweden AB (publ) (SUSRF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Surgical Science Sweden AB (publ) stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $251.55M | $231.83M | $212.47M | $188.24M |
| Cost of Revenue | $81.47M | $70.82M | $82.91M | $79.29M |
| Gross Profit | $170.07M | $161.01M | $129.55M | $108.96M |
| Gross Profit Ratio | $0.68 | $0.69 | $0.61 | $0.58 |
| R&D Expenses | $51.66M | $50.58M | $48.84M | $40.24M |
| SG&A Expenses | $72.24M | $60.66M | $63.29M | $46.63M |
| Operating Expenses | $130.95M | $115.23M | $110.05M | $86.87M |
| Total Costs & Expenses | $212.42M | $186.04M | $179.04M | $166.16M |
| Interest Income | $295000.00 | $0.00 | $4.38M | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $16.62M | -$1000.00 | $0.00 | $14.87M |
| EBITDA | $55.75M | $45.78M | $33.43M | $25.98M |
| EBITDA Ratio | $0.22 | $0.20 | $0.16 | $0.14 |
| Operating Income | $39.13M | $45.79M | $33.43M | $22.09M |
| Operating Income Ratio | $0.16 | $0.20 | $0.16 | $0.12 |
| Other Income/Expenses (Net) | $295000.00 | $7.24M | $4.38M | $1.86M |
| Income Before Tax | $39.42M | $53.02M | $37.81M | $27.84M |
| Income Before Tax Ratio | $0.16 | $0.23 | $0.18 | $0.15 |
| Income Tax Expense | $3.16M | $10.002M | $9.24M | $4.05M |
| Net Income | $36.26M | $43.02M | $28.57M | $23.79M |
| Net Income Ratio | $0.14 | $0.19 | $0.13 | $0.13 |
| EPS | $0.71 | $0.84 | $0.56 | $0.47 |
| Diluted EPS | $0.71 | $0.84 | $0.56 | $0.47 |
| Weighted Avg Shares Outstanding | $51.03M | $51.03M | $51.03M | $51.03M |
| Weighted Avg Shares Outstanding (Diluted) | $51.03M | $51.03M | $51.03M | $51.03M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan